메뉴 건너뛰기




Volumn 34, Issue 1, 2008, Pages 36-45

How useful are voluntary medication error reports? The case of warfarin-related medication errors

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

EID: 38549133509     PISSN: 15537250     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1553-7250(08)34006-9     Document Type: Article
Times cited : (39)

References (32)
  • 1
    • 0006092268 scopus 로고    scopus 로고
    • Institute of Medicine:, Washington, DC: National Academy Press
    • Institute of Medicine: To Err is Human: Building a Safer Health System. Washington, DC: National Academy Press, 1999.
    • (1999) Human: Building a Safer Health System
    • Err is, T.1
  • 2
    • 18644383685 scopus 로고    scopus 로고
    • Five years after To Err Is Human: What have we learned?
    • May 18
    • Leape L., Berwick D.: Five years after To Err Is Human: What have we learned? JAMA 293:2384-2390, May 18, 2005.
    • (2005) JAMA , vol.293 , pp. 2384-2390
    • Leape, L.1    Berwick, D.2
  • 3
    • 0141976196 scopus 로고    scopus 로고
    • Differences in the reporting of care-related patient injuries to existing reporting systems
    • Sep
    • Williams L., et al.: Differences in the reporting of care-related patient injuries to existing reporting systems. Jt Comm J Qual Patient Saf 29:460-467, Sep. 2003.
    • (2003) Jt Comm J Qual Patient Saf , vol.29 , pp. 460-467
    • Williams, L.1
  • 4
    • 14844292726 scopus 로고    scopus 로고
    • Error reporting and disclosure systems: Views from hospital leaders
    • Mar. 16
    • Weissman J.S., et al.: Error reporting and disclosure systems: Views from hospital leaders. JAMA 293:1359-1366, Mar. 16, 2005.
    • (2005) JAMA , vol.293 , pp. 1359-1366
    • Weissman, J.S.1
  • 5
    • 85185360267 scopus 로고    scopus 로고
    • U.S. Congress: Patient Safety and Quality Improvement Act of 2005, 109th Cong., S. 544, 2005.
    • U.S. Congress: Patient Safety and Quality Improvement Act of 2005, 109th Cong., S. 544, 2005.
  • 6
    • 22144474788 scopus 로고    scopus 로고
    • Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: The importance of reporting suspected reactions
    • Jun. 27
    • Wysowsky D., Swartz L.: Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: The importance of reporting suspected reactions. Arch Intern Med 165:1363-1369, Jun. 27, 2005.
    • (2005) Arch Intern Med , vol.165 , pp. 1363-1369
    • Wysowsky, D.1    Swartz, L.2
  • 7
    • 33646714934 scopus 로고    scopus 로고
    • last accessed Nov. 27, 2007
    • U.S. Food and Drug Administration: MedWatch Medical Product Safety Information. http://www.fda.gov/medwatch/safety.htm (last accessed Nov. 27, 2007).
    • MedWatch Medical Product Safety Information
  • 9
    • 2542538358 scopus 로고    scopus 로고
    • Voluntary anonymous reporting of medical errors for neonatal intensive care
    • Jun
    • Suresh G., et al.: Voluntary anonymous reporting of medical errors for neonatal intensive care. Pediatrics 113:1609-1618, Jun. 2004.
    • (2004) Pediatrics , vol.113 , pp. 1609-1618
    • Suresh, G.1
  • 10
    • 25444462539 scopus 로고    scopus 로고
    • Adverse reactions to anticoagulants and to antiplatelet drugs recorded by the German spontaneous reporting system
    • Tiaden J.D., et al.: Adverse reactions to anticoagulants and to antiplatelet drugs recorded by the German spontaneous reporting system. Semin Thromb Hemost 31(4):371-380, 2005.
    • (2005) Semin Thromb Hemost , vol.31 , Issue.4 , pp. 371-380
    • Tiaden, J.D.1
  • 11
    • 23644450583 scopus 로고    scopus 로고
    • Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001)
    • Thiessard F., et al.: Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001). Drug Saf 28(8):731-740, 2005.
    • (2005) Drug Saf , vol.28 , Issue.8 , pp. 731-740
    • Thiessard, F.1
  • 12
    • 3242892356 scopus 로고    scopus 로고
    • Under-reporting of serious adverse drug reactions in Sweden
    • Jul
    • Backstrom M., Mjorndal T., Dahlqvist R.: Under-reporting of serious adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf 13:483-487, Jul. 2004.
    • (2004) Pharmacoepidemiol Drug Saf , vol.13 , pp. 483-487
    • Backstrom, M.1    Mjorndal, T.2    Dahlqvist, R.3
  • 13
    • 0032978921 scopus 로고    scopus 로고
    • Spontaneous reporting of adverse drug reactions in elderly patients in Sicily (Italy)
    • Jul
    • Cutroneo P., et al.: Spontaneous reporting of adverse drug reactions in elderly patients in Sicily (Italy). Pharmacol Res 40:41-46, Jul. 1999.
    • (1999) Pharmacol Res , vol.40 , pp. 41-46
    • Cutroneo, P.1
  • 14
    • 23644458537 scopus 로고    scopus 로고
    • Adverse events and near miss reporting in the NHS
    • Aug
    • Shaw S., et al.: Adverse events and near miss reporting in the NHS. Qual Saf Health Care 14:279-283, Aug. 2005.
    • (2005) Qual Saf Health Care , vol.14 , pp. 279-283
    • Shaw, S.1
  • 15
    • 2942549279 scopus 로고    scopus 로고
    • Evaluation of the extent of under-reporting of serious adverse drug reactions: The case of toxic epidermal necrolysis
    • Mittmann N., et al.: Evaluation of the extent of under-reporting of serious adverse drug reactions: The case of toxic epidermal necrolysis. Drug Saf 27(7):477-487, 2004.
    • (2004) Drug Saf , vol.27 , Issue.7 , pp. 477-487
    • Mittmann, N.1
  • 16
    • 31544482442 scopus 로고    scopus 로고
    • Results of a survey on medical error reporting systems in Korean hospitals
    • Feb
    • Kim J., Bates D.W.: Results of a survey on medical error reporting systems in Korean hospitals. Int J Med Inform 75:148-155, Feb. 2006.
    • (2006) Int J Med Inform , vol.75 , pp. 148-155
    • Kim, J.1    Bates, D.W.2
  • 17
    • 0033082809 scopus 로고    scopus 로고
    • Warfarin therapy: Evolving strategies in anticoagulation
    • Feb. 1
    • Horton J., Bushwick B.: Warfarin therapy: Evolving strategies in anticoagulation. Am Fam Physician 53:635-646, Feb. 1, 1999.
    • (1999) Am Fam Physician , vol.53 , pp. 635-646
    • Horton, J.1    Bushwick, B.2
  • 18
    • 0035184096 scopus 로고    scopus 로고
    • Interactions between warfarin and herbal products, minerals and vitamins: A pharmacist's guide
    • Fall
    • Stenton B.: Interactions between warfarin and herbal products, minerals and vitamins: A pharmacist's guide. Can J Hosp Pharm 54:186-182, Fall 2001.
    • (2001) Can J Hosp Pharm , vol.54 , pp. 186-182
    • Stenton, B.1
  • 19
    • 0034235969 scopus 로고    scopus 로고
    • Potential interactions between alternative therapies and warfarin
    • Jul. 1
    • Heck A.: Potential interactions between alternative therapies and warfarin. Am J Health-Sys Pharm 57:1221-1227, Jul. 1, 2000.
    • (2000) Am J Health-Sys Pharm , vol.57 , pp. 1221-1227
    • Heck, A.1
  • 20
    • 0034622382 scopus 로고    scopus 로고
    • Oral anticoagulation self management and management by a specialist anticoagulation clinic: A randomised crossover comparison
    • Jul. 8
    • Cromheecke M., et al.: Oral anticoagulation self management and management by a specialist anticoagulation clinic: A randomised crossover comparison. Lancet 356:97-102, Jul. 8, 2000.
    • (2000) Lancet , vol.356 , pp. 97-102
    • Cromheecke, M.1
  • 21
    • 0033550473 scopus 로고    scopus 로고
    • A strucrured teaching and self-management program for patients receiving oral anticoagulation: A randomized controlled trial
    • Jan. 13
    • Sawicki P.: A strucrured teaching and self-management program for patients receiving oral anticoagulation: A randomized controlled trial. JAMA 281:182-183, Jan. 13, 1999.
    • (1999) JAMA , vol.281 , pp. 182-183
    • Sawicki, P.1
  • 22
    • 0034061293 scopus 로고    scopus 로고
    • A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation
    • May
    • Watzke H., et al.: A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. Thromb Haemost 83:661-665, May 2000.
    • (2000) Thromb Haemost , vol.83 , pp. 661-665
    • Watzke, H.1
  • 24
    • 15044360335 scopus 로고    scopus 로고
    • Suboptimal prescribing in elderly outpatients: Potentially harmful drug-drug and drug-disease combinations
    • Feb
    • Zhan C., et al.: Suboptimal prescribing in elderly outpatients: Potentially harmful drug-drug and drug-disease combinations. J Am Geriatr Soc 53:262-267, Feb. 2005.
    • (2005) J Am Geriatr Soc , vol.53 , pp. 262-267
    • Zhan, C.1
  • 25
    • 0035851288 scopus 로고    scopus 로고
    • Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting
    • Nov. 12
    • McCormick D., et al.: Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med 161:2458-2463, Nov. 12, 2001.
    • (2001) Arch Intern Med , vol.161 , pp. 2458-2463
    • McCormick, D.1
  • 26
    • 85185364329 scopus 로고    scopus 로고
    • United States Pharmacopeia: MEDMARX: Patient Safety Solutions. http://www.medmarx.com (last accessed Nov. 27, 2007).
    • United States Pharmacopeia: MEDMARX: Patient Safety Solutions. http://www.medmarx.com (last accessed Nov. 27, 2007).
  • 27
    • 77957792170 scopus 로고    scopus 로고
    • Available at, last accessed Nov. 27, 2007
    • The National Coordinating Council for Medication Error Reporting and Prevention: About Medication Errors: What Is a Medication Error? Available at http://www.nccmerp.org/aboutMedErrors.html (last accessed Nov. 27, 2007).
    • About Medication Errors: What Is a Medication Error
  • 28
    • 0037434858 scopus 로고    scopus 로고
    • Understanding and responding to adverse events
    • Mar. 13
    • Vincent C.: Understanding and responding to adverse events. N Engl J Med 348:1051-1056, Mar. 13, 2003.
    • (2003) N Engl J Med , vol.348 , pp. 1051-1056
    • Vincent, C.1
  • 29
    • 0032507502 scopus 로고    scopus 로고
    • Framework for analysing risk and safety in clinical medicine
    • Apr. 11
    • Vincent C., et al.: Framework for analysing risk and safety in clinical medicine. BMJ 316:1154-1157, Apr. 11, 1998.
    • (1998) BMJ , vol.316 , pp. 1154-1157
    • Vincent, C.1
  • 30
    • 32644434877 scopus 로고    scopus 로고
    • Potential benefits and problems with computerized prescriber order entry: Analysis of a voluntary medication error reporting database
    • Feb. 15
    • Zhan C., et al.: Potential benefits and problems with computerized prescriber order entry: Analysis of a voluntary medication error reporting database. Am J Health-Syst Pharm 63:353-358, Feb. 15, 2006.
    • (2006) Am J Health-Syst Pharm , vol.63 , pp. 353-358
    • Zhan, C.1
  • 31
    • 33244493122 scopus 로고    scopus 로고
    • Attitudes and barriers to incidence reporting: A collaborative hospital study
    • Jan
    • Evans S.M., et al.: Attitudes and barriers to incidence reporting: A collaborative hospital study. Qual Saf Health Care 15:39-43, Jan. 2006.
    • (2006) Qual Saf Health Care , vol.15 , pp. 39-43
    • Evans, S.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.